Drug Shortage Report for ATORVASTATIN
Report ID | 33117 |
Drug Identification Number | 02399385 |
Brand name | PMS-ATORVASTATIN |
Common or Proper name | ATORVASTATIN |
Company Name | PHARMASCIENCE INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-01-01 |
Actual start date | 2018-01-24 |
Estimated end date | 2018-02-05 |
Actual end date | 2018-02-08 |
Shortage status | Resolved |
Updated date | 2018-02-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-02-12 | French | Compare |
v6 | 2018-02-12 | English | Compare |
v5 | 2018-01-26 | French | Compare |
v4 | 2018-01-26 | English | Compare |
v3 | 2018-01-02 | English | Compare |
v2 | 2017-12-15 | French | Compare |
v1 | 2017-12-15 | English | Compare |
Showing 1 to 7 of 7